SEC Form 4 · accession 0001209191-18-060103
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · PACB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathy Ordonez
Officer — Chief Commercial Officer · Director
Period of report
Nov 27, 2018
Accepted (ET)
Nov 28, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001299130
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2018 | M | 25,000 | $2.90 | A | 68,750 | D | |
| Common StockF1 | Nov 27, 2018 | S | 25,000 | $7.54 | D | 43,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $2.90 | Nov 27, 2018 | A | 25,000 | D | Dec 15, 2017 | Nov 15, 2027 | Common Stock | 25,000 | 350,000 | D |
Explanation of responses
- F1This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F2The shares subject to the option will vest in equal monthly installments over a four year period.